Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1828185 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $0.56Day −2.91%Mkt cap $23M1Y −61.3%Off 52W high −69.6%Vol (1Y) 80.7%
Daily closing price, split-adjusted to the current basis; 2.7y shown of 678 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.1% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+0.20% |
| Top-10 13F concentration99.3% |
| Next report (est.)2026-10-29 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$52.3M |
| ROE−65.0% |
| ROIC−478.3% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−20.4% |
| 1Y−61.3% |
| Since incept. (ann.)−51.9% |
Total return through 2026-07-30 · series begins 2023-11-07. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)80.7% |
| Ann. volatility (3Y)95.0% |
| Sharpe (1Y)−0.87 |
| Sharpe (3Y)−0.31 |
| Max drawdown (1Y)−65.9% |
| Max drawdown (3Y)−86.8% |
| Beta (3Y vs SPY)0.23 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| M&G PLC | 5.2M | $5M | 12.72% | +0.0% |
| HSG Holding Ltd | 1.4M | $1M | 3.48% | +0.0% |
| GLR Partners, LLC | 1.2M | $707,482 | 3.04% | new |
| DC Funds, LP | 642,204 | $365,414 | 1.57% | +0.0% |
| Rangeley Capital, LLC | 159,465 | $90,736 | 0.39% | +88.8% |
| RENAISSANCE TECHNOLOGIES LLC | 151,000 | $85,919 | 0.37% | +5.5% |
| Johns Hopkins University | 122,237 | $69,553 | 0.30% | +0.0% |
| CITADEL ADVISORS LLC | 118,996 | $68,125 | 0.29% | +0.2% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-04-30 | −$0.14 | — | — | — |
| 2025-09-30 | 2025-11-07 | −$0.36 | — | $0 | −100.0% |
| 2025-06-30 | 2025-08-07 | −$0.52 | — | — | — |
| 2025-03-31 | 2025-05-07 | −$0.49 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-10-29 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
